Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

NCT01570790 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Combretastatin A4 Phosphate
Age-related Macular Degeneration
AMD
CNV
Choroidal Neovascularization

Interventions

DRUG: Combretastatin A-4 phosphate
DRUG: Combretastatin A-4 Phosphate
DRUG: Combretastatin A-4 Phosphate

Sponsor

Johns Hopkins University